Recalls from Ajanta Pharma USA Inc

• Ajanta Pharma Ranolazine Extended-Release Tablets (opens in a new tab)
  Moderate risk, FDA, Sep 25, 2026, Drug dissolving problem
• Ajanta Pharma Fluphenazine Hydrochloride Tablets (opens in a new tab)
  Low risk, FDA, Sep 8, 2026, Drug impurity
• Ajanta Pharma Fenofibrate Capsules (opens in a new tab)
  Moderate risk, FDA, Jun 22, 2026, Manufacturing problem
• Ajanta Pharma Aripiprazole Tablets (opens in a new tab)
  Moderate risk, FDA, Jun 15, 2026, Labeling error

Data: Recall Canary (opens in a new tab)